» Articles » PMID: 20356776

Clinical Spectrum of Ankylosing Spondylitis in Korea

Overview
Specialty Rheumatology
Date 2010 Apr 2
PMID 20356776
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The aim of this study was to determine the clinical profile of ankylosing spondylitis (AS) in Korea.

Methods: A total of 732 men and 98 women with AS were recruited for the cross-sectional component of the Hanyang University ankylosing spondylitis (HYAS) Study. All participants completed extensive questionnaires about their medical and personal histories, and two rheumatologists concomitantly performed clinical evaluation and previous medical record reviews for all participants.

Results: The mean age of onset (SD) was 20.9 (8.1) years. Three hundred and ninety-one patients (47.1%) were found to have a history of peripheral arthritis. Six hundred and four patients (73.9%) were found to have a history of hip joint involvement. Two hundred and thirty-six patients (28.7%) were found to be juvenile-onset AS (JoAS) patients. The frequency of uveitis differed between the sexes (28.2% of men vs 40.8% of women; p=0.03; OR: 1.63; 95% CI: 1.05-2.53). Peripheral arthritis (p<0.001; OR: 4.19; 95% CI: 2.98-5.88) and hip joint involvement (p<0.001; OR: 2.76; 95% CI; 1.77-4.29) were more frequent in JoAS group. HLA-B27 positive cases had a significantly younger age of symptom onset (by 5.3 years), more uveitis, and a higher frequency of hip joint involvement than HLA-B27 negative patients.

Conclusions: The clinical features of our patients are largely similar to those in other studies, with a few noticeable differences: 1) AS patients in Korea have a higher prevalence of peripheral arthritis and hip joint involvement; 2) female patients have more uveitis, and; 3) JoAS is common in our group.

Citing Articles

Clonorchis sinensis excretory/secretory proteins ameliorate inflammation in rheumatoid arthritis and ankylosing spondylitis.

Kim M, Yoo H, Lee Y, Jang H, Shim S, Won E Parasit Vectors. 2025; 18(1):85.

PMID: 40038824 PMC: 11881509. DOI: 10.1186/s13071-025-06677-3.


Primary focal segmental glomerulosclerosis in a patient with ankylosing spondylitis: A rare presentation requiring a broad differential in nephrotic syndrome.

Zardoost P, Tyabuddin S, Cantu A, Abu-Jubara M, Mittlesteadt J, Wehrum H Clin Case Rep. 2024; 12(5):e8901.

PMID: 38751961 PMC: 11093901. DOI: 10.1002/ccr3.8901.


PLCG2 and IFNAR1: The Potential Biomarkers Mediated by Immune Infiltration and Osteoclast Differentiation of Ankylosing Spondylitis in the Peripheral Blood.

Han B, Xie Q, Liang W, Yin P, Qu X, Hai Y Mediators Inflamm. 2024; 2024:3358184.

PMID: 38223749 PMC: 10787051. DOI: 10.1155/2024/3358184.


Clinical profile and treatment utilisation based on HLA-B*27 status in axial spondyloarthritis: results from ASAS-PerSpA study.

Chaudhary H, Lopez-Medina C, Khan M, Dougados M, Magrey M RMD Open. 2023; 9(3).

PMID: 37491128 PMC: 10373694. DOI: 10.1136/rmdopen-2023-003179.


Serum miR-3620-3p as a Novel Biomarker for Ankylosing Spondylitis.

Lee H, Park K, Kim H, Choi A, Jin S, Kim T J Rheum Dis. 2023; 29(1):33-39.

PMID: 37476698 PMC: 10324918. DOI: 10.4078/jrd.2022.29.1.33.